<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Netvouz - link info</title>
<link>http://netvouz.com/url/c1c05febe430f1aab39271d33ec886e4?feed=rss</link>
<description>Info about a link</description>
<item><title>Prohost Biotechnology. Biotech Blog, News and Comments. » Northwest Biotherapeutics (NWBO :OB)</title>
<link>http://www.prohostbiotech.com/blog/category/northwest-biotherapeutics-nwbo-ob/</link>
<description>Northwest Biotherapeutics (NWBO :OB) announced that it has received Authorization for Use to make its DCVax®-Brain commercially available for treatment of brain cancer patients in Switzerland. DCVax®-Brain is the first commercially available therapeutic</description>
<category domain="http://netvouz.com/bakerfranklin?category=3194230226375454051"></category>
<author>bakerfranklin</author>
<pubDate>Sun, 23 Dec 2007 02:23:01 GMT</pubDate>
</item><item><title>Prohost Biotechnology. Biotech Blog, News and Comments. » Northwest Biotherapeutics (NWBO :OB)</title>
<link>http://www.prohostbiotech.com/blog/category/northwest-biotherapeutics-nwbo-ob/</link>
<description>Barron’s believes that shares of Gilead Sciences (GILD) could soar 20 percent to 25 percent on strong demand for its existing AIDS and flu drugs as well as from new products in the pipeline. Why not if the earnings are climbing by double digit every yea</description>
<category domain="http://netvouz.com/johndossman?category=3297066165142403045"></category>
<author>johndossman</author>
<pubDate>Thu, 20 Dec 2007 00:01:01 GMT</pubDate>
</item></channel></rss>